
Phytomedicine Plus, Journal Year: 2024, Volume and Issue: unknown, P. 100667 - 100667
Published: Oct. 1, 2024
Language: Английский
Phytomedicine Plus, Journal Year: 2024, Volume and Issue: unknown, P. 100667 - 100667
Published: Oct. 1, 2024
Language: Английский
Scientific African, Journal Year: 2024, Volume and Issue: unknown, P. e02509 - e02509
Published: Dec. 1, 2024
Language: Английский
Citations
11Case Studies in Thermal Engineering, Journal Year: 2024, Volume and Issue: 61, P. 105074 - 105074
Published: Sept. 1, 2024
The complete investigation of the solubility Ceftriaxone sodium drug has not yet been conducted. This communication investigates in supercritical CO2 (SC-CO2) for first time. measurements were performed using utilizing UV-vis analysis under different operation conditions (at P (bar) = 120-270 and T (K) 308-338). results demonstrated that ranged from 0.90 × 10-6 to 8.01 10-6. mole fraction increases proportionally with an increase pressure, while maintaining a constant temperature. However, crossover was noted. behavior SC-CO2 modeled by Peng-Robinson equation state (PR EoS) Kwak-Mansoori van der Waals mixing rules seven semi-empirical correlations (Bian et al., Kumar-Johnston, Chrastil, Garlapati-Madras, Bartle Sung-Shim Sodeifian al.,). vaporization, total solvation enthalpies sodium/SC-carbon dioxide system obtained KJ, al. correlations. evaluation two methods absolute average relative deviation (AARD%). Both models exhibited satisfactory level agreement experimental data. Finally, PR/KM EoS Chrastil models, AARD% values 8.70% 8.10% respectively, showed superior precision accurately fitting
Language: Английский
Citations
9Journal of CO2 Utilization, Journal Year: 2025, Volume and Issue: 92, P. 103021 - 103021
Published: Jan. 13, 2025
Language: Английский
Citations
1Journal of Chemical & Engineering Data, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 15, 2025
This study investigates the solubility of Baclofen in supercritical CO2, which is essential for developing an efficient drug delivery system using processes. Solubility measurements were carried out both with and without presence various cosolvents (ethanol dimethyl sulfoxide (DMSO)), across a temperature range 308–338 K pressure 12–30 MPa. exhibited ranging from 1.62 × 10–5 to 2.30 mole fractions pure CO2. In cosolvents, increased 5.76 12.79 ethanol 3.50 7.02 DMSO. Indeed, addition DMSO by approximately 3.55–5.56 times 2.15–3.05 times, respectively. Several density-based empirical models thermodynamic (Soave–Redlich–Kwong (SRK) Peng–Robinson (PR) equations state) used correlate data. Jafari Nejad's model CO2–Baclofen Jouyban's CO2–ethanol/DMSO–Baclofen systems displayed higher consistency. Also, PR showed better accuracy correlating while SRK outperformed CO2–ethanol/DMSO cosolvents. Moreover, machine learning exceptional accuracy, over 99% predictions closely matching experimental data, emphasizing its outstanding performance.
Language: Английский
Citations
1Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)
Published: Jan. 26, 2025
The supercritical antisolvent (SAS) method can effectively improve the bioavailability of poorly water-soluble drugs. However, current equipment and processes were not fully developed, making industrialization difficult to achieve. Therefore, an externally adjustable annular gap nozzle its supporting designed. Curcumin was used as a model drug, ethanol solvent, carbon dioxide (SC-CO2) antisolvent. Building on single-factor experiments, Box-Behnken Design-Response Surface Methodology (BBD-RSM) employed systematically investigate effects four process parameters—crystallizer pressure (12–16 MPa), crystallizer temperature (313–323 K), solution concentration (1–2 mg/mL), CO2/solution flow rate ratio (133–173 g/g)—on morphology particle size curcumin particles. Using scanning electron microscopy (SEM) dynamic light scattering (DLS) analyses, morphologies mean diameter ranges examined. To look into how SAS affects TML's chemical physical characteristics, X-ray diffraction analysis (XRD) Fourier-transform infrared spectroscopy (FT-IR) further performed. Experimental results show that, had greatest effect size, followed by concentration, while least influence. optimum conditions are operational set with 15 MPa, 320 K, 1.2 mg/mL, 134 g/g, resulting in submicron particles average 808 nm being obtained. This study demonstrated feasibility associated process, showcasing significant potential for reducing enhancing
Language: Английский
Citations
1Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)
Published: Sept. 27, 2024
Language: Английский
Citations
7Journal of CO2 Utilization, Journal Year: 2024, Volume and Issue: 91, P. 102995 - 102995
Published: Dec. 15, 2024
Citations
6Journal of Toxicology, Journal Year: 2025, Volume and Issue: 2025(1)
Published: Jan. 1, 2025
Background: The safety of combining tamsulosin (an allopathic drug) and Croton membranaceus aqueous extract, a medicinal plant for managing benign prostatic hyperplasia (BPH), was investigated. Methods: roots CM were used processed into water extract by maceration decoction. Thirty-five Sprague Dawley rats divided seven groups five each. Groups 2-7 orchidectomy/testosterone injections BPH-induced. Group 1 designated as the control group. 2 model group (untreated). 3 treated with 0.03 mg/kg b.wt. tamsulosin. 4 received 30 (low dose [LD]). 5 300 (high [HD]); 6 plus CM. 7 Tamsulosin administered oral gavage 28 days. Prostate-specific antigen (PSA) levels, renal liver function tests, histology assessed. Results: PSA decreased after treatment LD (0.44 ± ng/mL) (0.43 0.04 combined, compared (0.63 (p < 0.006). Prostate gland/accessory organ weights follows: HD/T LD/T HD model. In group, acini appeared empty fluid contained fatty droplets slender outer boundary that had very little active mucous surface. At higher dose, caused reduction in sizes shapes most being having surfaces. Conclusion: results suggest combination C. does not provide additional therapeutic benefits treating BPH. Relative better evaluation metric than total weights.
Language: Английский
Citations
0Process Safety and Environmental Protection, Journal Year: 2025, Volume and Issue: unknown
Published: April 1, 2025
Language: Английский
Citations
0European Journal of Pharmaceutics and Biopharmaceutics, Journal Year: 2025, Volume and Issue: 211, P. 114720 - 114720
Published: April 16, 2025
Language: Английский
Citations
0